|
|
|
|
|
FDA-approved product labeling and responsible promotion
|
|
Diversion control in the supply chain
|
|
Education
|
|
Surveillance
|
|
Intervention
|
|
Extensive training of professional sales representatives on:
|
|
|
—
|
Regulations and laws
|
|
—
|
Appropriate use of opioid analgesics
|
|
—
|
Risk management principles and responsibilities
|
|
|
PROMISE™ initiative
|
|
|
—
|
Education for clinicians, pharmacists, and patients
|
|
—
|
Pain management resource kit
|
|
|
 |
 |
View additional information on the Risk Minimization Action Plan (RiskMAP). |
|
|